● Actively exploited (CISA KEV)

CVE-2023-38950ZKTeco BioTime Path Traversal Vulnerability

Vendor
ZKTeco
Product
BioTime
Added to KEV
2025-05-19
Remediation due
2025-06-09
Exploit probability (EPSS)
84.7% · Critical
Used in ransomware
Yes

Overview

CVE-2023-38950 is a security vulnerability affecting ZKTeco BioTime (ZKTeco BioTime Path Traversal Vulnerability). It appears in the CISA Known Exploited Vulnerabilities catalog, added on 2025-05-19, which means it has been confirmed exploited in real-world attacks — not a theoretical risk.

Risk & exploitation

EPSS (exploit prediction) score: 84.7% — Critical likelihood of exploitation in the next 30 days. It is known to be used in ransomware campaigns.

Remediation

Apply the vendor's security update for ZKTeco BioTime without delay. CISA's remediation due date for federal agencies is 2025-06-09. Vendor/agency notes: ZKTeco BioTime contains a path traversal vulnerability in the iclock API that allows an unauthenticated attacker to read arbitrary files via supplying a crafted payload. Prioritize this CVE over non-exploited issues, and verify no compromise has already occurred.

References

Data is sourced from public feeds (CISA KEV, FIRST EPSS, Exploit-DB) and refreshed automatically.